Tamoxifen resistance in breast cancer
- 30 June 1993
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 14 (3), 173-188
- https://doi.org/10.1016/1040-8428(93)90008-r
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Growth factors in breast cancer: Mitogenesis to transformationThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Multidrug Resistance: P-glycoprotein and Its Allies--The Elusive FoesJNCI Journal of the National Cancer Institute, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growthBiochemical and Biophysical Research Communications, 1987
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sitesBreast Cancer Research and Treatment, 1985
- Interaction of non-steroidal antiestrogens with dopamine receptor bindingThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation.The Journal of cell biology, 1984
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Differential binding of antiestrogens by rat uterine and chick oviduct cytosolBiochemical and Biophysical Research Communications, 1979